Diabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell

K Masur1, C Vetter, A Hinz

  • 1Institute of Immunology and Experimental Oncology, University Witten/Herdecke, Stockumer Str. 10, Witten 58448, Germany. kai.masur@inp-greifswald.de

British Journal of Cancer
|December 24, 2010
PubMed
Abstract

Insights

High glucose and insulin levels promote cancer cell proliferation and migration by activating key signaling pathways. This study investigates the molecular mechanisms linking hyperglycemia and hyperinsulinemia to tumor growth and metastasis.

Area of Science:

  • Oncology
  • Metabolic Diseases
  • Molecular Biology

Background:

  • Epidemiological studies link metabolic syndrome and type 2 diabetes mellitus (DM T2) to increased cancer progression.
  • The precise mechanisms by which high glucose and insulin influence cancer cell gene activity and signaling pathways remain incompletely understood.

Purpose of the Study:

  • To investigate the impact of diabetogenic glucose and insulin concentrations on cancer cell proliferation and migration.
  • To elucidate how high glucose and insulin levels affect gene and signal cascade activities, focusing on kinases involved in tumor cell behavior.

Main Methods:

  • Analysis of over 400 gene signatures related to cell cycle, cell movement, and signal transduction.
  • Transcriptome analysis of kinases (PKCα, PI3K), cadherins, integrins, and cyclins under physiological (5.5 mM) versus diabetogenic (11 mM) glucose concentrations, with and without insulin.

Main Results:

  • High glucose (11 mM) and insulin (100 ng/ml) significantly promoted proliferation in multiple tumor cell lines (HT29, SW480, MCF-7, MDA MB468, PC3, T24).
  • Elevated glucose concentrations increased tumor cell motility in 3D-migration assays.
  • Increased migratory activity under high glucose and insulin was mediated by the activation of PI3K, PKCα, and MLCK, confirmed by pharmacological inhibitors.

Conclusions:

  • This study provides molecular and functional evidence for how hyperglycemia and hyperinsulinemia can drive tumor cell proliferation and motility.
  • Findings offer insights into the potential mechanisms by which metabolic dysregulation contributes to cancer progression in patients.

Related Concept Videos

Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...